110 related articles for article (PubMed ID: 21597503)
1. Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells.
Wang F; Ding W; Wang J; Jing R; Wang X; Cong H; Wang Y; Ju S; Wang H
Cancer Gene Ther; 2011 Jul; 18(7):500-9. PubMed ID: 21597503
[TBL] [Abstract][Full Text] [Related]
2. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
3. [Effect of APRIL on growth and apoptosis in transplanted tumor with human colorectal cancer cell line SW480 in nude mice].
Wang JC; Ding WF; Sun BL; Jing RR; Huang H; Wang HM
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):570-4. PubMed ID: 21122406
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous knockdown of APRIL via multiple shRNAs reduces the malignancy of SW480 cells.
Li H; Shao K; Wang J; Wang G; Xu J; Cao J; Ju S; Wang H
Oncol Rep; 2012 Nov; 28(5):1613-8. PubMed ID: 22923013
[TBL] [Abstract][Full Text] [Related]
5. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells.
Ding W; Wang J; Sun B; Ju S; Yuan H; Wang X; Wang Y; Wang H
Clin Biochem; 2009 Nov; 42(16-17):1694-8. PubMed ID: 19573525
[TBL] [Abstract][Full Text] [Related]
6. Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo.
Wang F; Chen L; Mao ZB; Shao JG; Tan C; Huang WD
Oncol Rep; 2008 Jul; 20(1):135-9. PubMed ID: 18575728
[TBL] [Abstract][Full Text] [Related]
7. [Expression of APRIL in colorectal carcinoma tissues and effects of chemotherapeutic agents on APRIL expression in colorectal carcinoma SW480 cells].
Guo YW; Wen ZF; Zheng FP; Li YW; Feng ZY
Ai Zheng; 2008 Apr; 27(4):369-73. PubMed ID: 18423122
[TBL] [Abstract][Full Text] [Related]
8. Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA.
Wang J; Ding W; Sun B; Jing R; Huang H; Shi G; Wang H
Mol Cell Biochem; 2012 Apr; 363(1-2):1-10. PubMed ID: 22170570
[TBL] [Abstract][Full Text] [Related]
9. The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells.
Li XB; Jiao S; Sun H; Xue J; Zhao WT; Fan L; Wu GH; Fang J
Cancer Lett; 2011 Oct; 309(2):137-44. PubMed ID: 21696885
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
Luo H; Zou J; Dong Z; Zeng Q; Wu D; Liu L
Biochem J; 2012 Mar; 442(2):311-21. PubMed ID: 22132820
[TBL] [Abstract][Full Text] [Related]
11. mTOR signaling pathway is a target for the treatment of colorectal cancer.
Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
[TBL] [Abstract][Full Text] [Related]
12. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo.
Yin A; Jiang Y; Zhang X; Zhao J; Luo H
Eur J Pharmacol; 2010 Dec; 649(1-3):120-6. PubMed ID: 20869960
[TBL] [Abstract][Full Text] [Related]
13. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.
Kaneda H; Arao T; Tanaka K; Tamura D; Aomatsu K; Kudo K; Sakai K; De Velasco MA; Matsumoto K; Fujita Y; Yamada Y; Tsurutani J; Okamoto I; Nakagawa K; Nishio K
Cancer Res; 2010 Mar; 70(5):2053-63. PubMed ID: 20145154
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo.
Vidic S; Markelc B; Sersa G; Coer A; Kamensek U; Tevz G; Kranjc S; Cemazar M
Cancer Gene Ther; 2010 Jun; 17(6):409-19. PubMed ID: 20094071
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.
Matsuda Y; Ishiwata T; Yamahatsu K; Kawahara K; Hagio M; Peng WX; Yamamoto T; Nakazawa N; Seya T; Ohaki Y; Naito Z
Cancer Lett; 2011 Oct; 309(2):209-19. PubMed ID: 21745712
[TBL] [Abstract][Full Text] [Related]
16. APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.
Wang G; Wang F; Ding W; Wang J; Jing R; Li H; Wang X; Wang Y; Ju S; Wang H
PLoS One; 2013; 8(1):e55298. PubMed ID: 23383143
[TBL] [Abstract][Full Text] [Related]
17. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
19. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
20. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
